Patents Assigned to Belite Bio, LLC
  • Formulations of RBP4 inhibitors and methods of use
    Patent number: 11951100
    Abstract: Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as macular degeneration and the like.
    Type: Grant
    Filed: September 1, 2023
    Date of Patent: April 9, 2024
    Assignee: Belite Bio, LLC
    Inventors: Yu-Hsin Tom Lin, Cheng-Chi Irene Wang